Sun Says FDA Clears Two U.S. Drug Facilities Of GMP Violations
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical said its Caraco Pharmaceutical Laboratories unit in the U.S. has been returned to compliance with good manufacturing practices, having fixed problems that led to U.S. FDA action in 2009.